2018
DOI: 10.1007/s12350-017-0921-0
|View full text |Cite
|
Sign up to set email alerts
|

Is it time for personalized cardiac resynchronization therapy

Abstract: Cardiac resynchronization therapy (CRT) in appropriately selected patients can significantly improve left ventricular function and New York Heart Association (NYHA) class. 1-3 CRT trials' inclusion criteria have been based solely on QRS duration with left ventricular (LV) lead implantation in the posterolateral branch of the coronary sinus as the preferred location. Using these guidelines, 60-70% of the CRT recipients respond with improvement in symptoms and/or ejection fraction. Response rate is much higher i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 11 publications
(11 reference statements)
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?